Package 72189-145-30

{"route": ["ORAL"], "spl_id": "397f5fde-810b-642f-e063-6294a90ae47b", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["403957"], "spl_set_id": ["b3ee8325-bcb2-43fd-e053-2a95a90a08c8"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["direct rx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-145-30)", "package_ndc": "72189-145-30", "marketing_start_date": "20201112"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (72189-145-90)", "package_ndc": "72189-145-90", "marketing_start_date": "20201112"}], "brand_name": "TADALAFIL", "product_id": "72189-145_397f5fde-810b-642f-e063-6294a90ae47b", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "72189-145", "generic_name": "TADALAFIL", "labeler_name": "direct rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA209654", "marketing_category": "ANDA", "marketing_start_date": "20201112", "listing_expiration_date": "20261231"}